What does Clearpoint Neuro, Inc. do?

Jun 22 2025 06:49 PM IST
share
Share Via
Clearpoint Neuro, Inc. is a medical device company specializing in minimally invasive surgical procedures in the brain and heart using MRI guidance. As of March 2025, it reported net sales of $8 million and a net loss of $6 million, with a market cap of $315.72 million.
Overview:
Clearpoint Neuro, Inc. is a medical device company that develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance, operating within the Pharmaceuticals & Biotechnology industry and classified as a micro-cap company.

Financial Snapshot:
Most recent Net Sales: 8 Million (Quarterly Results - Mar 2025)
Most recent Net Profit: -6 Million (Quarterly Results - Mar 2025)
Market cap: USD 315.72 Million (Micro Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -0.59
Return on Equity: -104.04%
Price to Book: 15.80

Contact Details:
Address: 5 Musick, IRVINE CA : 92618-1638
Tel: 1 949 9006833
Fax: 1 949 9006834
Website: https://www.clearpointneuro.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News